“Dupilumab with Concomitant Topical Corticosteroids in Atopic Dermatitis Patients who are Inadequately Controlled with or Medically Inadvisable for Cyclosporine A: a Phase 3 Clinical Trial (LIBERTY AD CAFE)” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s37. doi:10.25251/skin.1.supp.36.